• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1987 - 1999年与人类免疫缺陷病毒感染相关的消瘦综合征的发病率及预测因素变化

Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999.

作者信息

Smit Ellen, Skolasky Richard L, Dobs Adrian S, Calhoun Bridget C, Visscher Barbara R, Palella Frank J, Jacobson Lisa P

机构信息

Department of Social and Preventive Medicine, School of Medicine and Biological Sciences, University at Buffalo, Buffalo, NY 14214-3000, USA.

出版信息

Am J Epidemiol. 2002 Aug 1;156(3):211-8. doi: 10.1093/aje/kwf039.

DOI:10.1093/aje/kwf039
PMID:12142255
Abstract

The authors examined the impact of potent antiretroviral therapy (ART) on the diagnosis of wasting syndrome in the Multicenter AIDS Cohort Study. Study time was divided into the periods 1988-1990, 1991-1993, 1994-1995, and 1996-1999 to correspond to different treatment eras. The proportion of acquired immunodeficiency syndrome diagnoses in which wasting was present increased from 5% in 1988-1990 to 7.1% in 1991-1993, 7.7% in 1994-1995, and 18.9% in 1996-1999. The incidence of wasting per 1,000 person-years increased from 7.5 in 1988-1990 to 14.4 in 1991-1993 and 22.1 in 1994-1995; it decreased to 13.4 in 1996-1999. Fewer patients with wasting had low hemoglobin and hematocrit levels and reported oral thrush in 1996-1999 than in any other period. Analysis of change in body mass index (weight (kg)/height (m)(2)) after wasting showed a faster return to prewasting levels in 1994-1995 and 1996-1999 than in earlier periods. Case-control analysis showed that wasting prior to 1996 was weakly associated with fatigue (p = 0.10), low hemoglobin (p = 0.11), and CD4-positive T-lymphocyte count (p = 0.04). During 1996-1999, wasting was weakly associated with diarrhea (p = 0.05) and potent ART (p = 0.097). Predictors of wasting have changed with potent ART. Further research is needed to determine whether lipodystrophy may be misdiagnosed as wasting syndrome.

摘要

在多中心艾滋病队列研究中,作者们研究了高效抗逆转录病毒疗法(ART)对消瘦综合征诊断的影响。研究时间分为1988 - 1990年、1991 - 1993年、1994 - 1995年和1996 - 1999年这几个时期,以对应不同的治疗时代。伴有消瘦的获得性免疫缺陷综合征诊断比例从1988 - 1990年的5%增至1991 - 1993年的7.1%、1994 - 1995年的7.7%以及1996 - 1999年的18.9%。每1000人年的消瘦发病率从1988 - 1990年的7.5增至1991 - 1993年的14.4以及1994 - 1995年的22.1;在1996 - 1999年降至13.4。与其他任何时期相比,1996 - 1999年消瘦患者中血红蛋白和血细胞比容水平低以及报告有鹅口疮的情况较少。对消瘦后体重指数(体重(千克)/身高(米)²)变化的分析显示,1994 - 1995年和1996 - 1999年比早期更快恢复到消瘦前水平。病例对照分析表明,1996年之前的消瘦与疲劳(p = 0.10)、低血红蛋白(p = 0.11)以及CD4阳性T淋巴细胞计数(p = 0.04)弱相关。在1996 - 1999年期间,消瘦与腹泻(p = 0.05)以及高效ART(p = 0.097)弱相关。消瘦的预测因素已随高效ART而改变。需要进一步研究以确定脂肪代谢障碍是否可能被误诊为消瘦综合征。

相似文献

1
Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999.1987 - 1999年与人类免疫缺陷病毒感染相关的消瘦综合征的发病率及预测因素变化
Am J Epidemiol. 2002 Aug 1;156(3):211-8. doi: 10.1093/aje/kwf039.
2
Increase in body cell mass and decrease in wasting are associated with increasing potency of antiretroviral therapy for HIV infection.身体细胞质量的增加和消瘦的减少与抗逆转录病毒疗法治疗HIV感染的效力增强相关。
AIDS Patient Care STDS. 2005 Apr;19(4):216-23. doi: 10.1089/apc.2005.19.216.
3
Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003.1995年至2003年期间,一组感染HIV的患者出现5%或更高意外体重减轻的风险增加。
J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):70-6. doi: 10.1097/01.qai.0000159627.54149.2e.
4
Thrush and fever as markers of immune competence in the era of highly active antiretroviral therapy.在高效抗逆转录病毒治疗时代,鹅口疮和发热作为免疫能力的标志物。
AIDS Res Hum Retroviruses. 2001 Sep 20;17(14):1311-6. doi: 10.1089/08892220152596551.
5
HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages?高效抗逆转录病毒治疗时代的HIV相关消瘦:单核细胞和巨噬细胞中残留HIV感染的一种综合征?
Clin Infect Dis. 2005 Jun 15;40(12):1846-8. doi: 10.1086/430376. Epub 2005 May 3.
6
AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change.英国艾滋病界定疾病:肺孢子菌肺炎预防措施的影响及十二年的变化
Int J STD AIDS. 1996 Jul;7(4):252-7. doi: 10.1258/0956462961917924.
7
Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV Infection and its therapies.与HIV感染及其治疗相关的身体形态变化和脂质异常的诊断与管理。
Top HIV Med. 2004 Jul-Aug;12(3):89-93.
8
Vitamin supplements, socioeconomic status, and morbidity events as predictors of wasting in HIV-infected women from Tanzania.维生素补充剂、社会经济地位及发病事件作为坦桑尼亚感染艾滋病毒妇女消瘦的预测因素
Am J Clin Nutr. 2005 Oct;82(4):857-65. doi: 10.1093/ajcn/82.4.857.
9
Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus.在一大群感染人类免疫缺陷病毒的女性中按指征选择强效抗逆转录病毒疗法的使用情况
Am J Epidemiol. 2000 Nov 15;152(10):923-33. doi: 10.1093/aje/152.10.923.
10
Role of acquired immune deficiency syndrome-defining conditions in human immunodeficiency virus-associated wasting.获得性免疫缺陷综合征定义疾病在人类免疫缺陷病毒相关消瘦中的作用。
Clin Infect Dis. 2003;37 Suppl 2:S81-4. doi: 10.1086/375894.

引用本文的文献

1
Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort.定义、负担和预测因素的 HIV 相关消瘦和低体重的 OPERA 队列。
AIDS Res Hum Retroviruses. 2023 Dec;39(12):636-643. doi: 10.1089/AID.2023.0048. Epub 2023 Aug 18.
2
Nutritional aberration and related morphological disorders among patients with human immunodeficiency virus infection on combination antiretroviral therapy (cART) in Ghana: A retrospective study.加纳接受联合抗逆转录病毒疗法(cART)的人类免疫缺陷病毒感染患者的营养异常及相关形态学紊乱:一项回顾性研究。
Heliyon. 2022 Aug 28;8(8):e10436. doi: 10.1016/j.heliyon.2022.e10436. eCollection 2022 Aug.
3
Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug.
抗逆转录病毒治疗开始后体重指数的变化:核心药物类别不同。
Viruses. 2022 Jul 29;14(8):1677. doi: 10.3390/v14081677.
4
Overweight and Obesity among Recipients of Antiretroviral Therapy at HIV Clinics in Gaborone, Botswana: Factors Associated with Change in Body Mass Index.博茨瓦纳哈博罗内艾滋病诊所接受抗逆转录病毒治疗患者的超重与肥胖:与体重指数变化相关的因素
AIDS Res Treat. 2020 Jan 4;2020:8016791. doi: 10.1155/2020/8016791. eCollection 2020.
5
Obesity Affects the Association of Bioelectrical Impedance Phase Angle With Mortality in People Living With HIV.肥胖会影响人体生物电阻抗相位角与 HIV 感染者死亡率之间的关联。
J Assoc Nurses AIDS Care. 2020 Jan-Feb;31(1):51-59. doi: 10.1097/JNC.0000000000000077.
6
Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.应用生长曲线模型确定南非抗逆转录病毒治疗的 HIV 阳性成年人中不同 BMI 轨迹组。
AIDS. 2019 Nov 1;33(13):2049-2059. doi: 10.1097/QAD.0000000000002302.
7
Predictive effects of body mass index on immune reconstitution among HIV-infected HAART users in China.体重指数对中国接受高效抗逆转录病毒治疗的 HIV 感染者免疫重建的预测作用。
BMC Infect Dis. 2019 May 2;19(1):373. doi: 10.1186/s12879-019-3991-6.
8
Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients.血浆吲哚胺 2,3-双加氧酶,人免疫缺陷病毒感染患者结核病的生物标志物。
Clin Infect Dis. 2017 Oct 15;65(8):1356-1358. doi: 10.1093/cid/cix550.
9
Physical fitness characteristics of active duty US Air Force members with HIV infection.美国现役感染艾滋病毒空军人员的体能特征。
Medicine (Baltimore). 2016 Nov;95(44):e5227. doi: 10.1097/MD.0000000000005227.
10
Long-term impact of HIV wasting on physical function.艾滋病消瘦对身体功能的长期影响。
AIDS. 2016 Jan 28;30(3):445-54. doi: 10.1097/QAD.0000000000000932.